-
1
-
-
0344406127
-
The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes
-
Valdes F, Alvarez AM, Locascio A, Vega S, Herrera B, et al. (2002) The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes. Mol Cancer Res 1: 68-78.
-
(2002)
Mol Cancer Res
, vol.1
, pp. 68-78
-
-
Valdes, F.1
Alvarez, A.M.2
Locascio, A.3
Vega, S.4
Herrera, B.5
-
2
-
-
0037148532
-
Ras and TGF-[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways
-
Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, et al. (2002) Ras and TGF-[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 156: 299-313.
-
(2002)
J Cell Biol
, vol.156
, pp. 299-313
-
-
Janda, E.1
Lehmann, K.2
Killisch, I.3
Jechlinger, M.4
Herzig, M.5
-
3
-
-
0032547895
-
TGF-beta signaling is necessary for carcinoma cell invasiveness and metastasis
-
Oft M, Heider KH, Beug H, (1998) TGF-beta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8: 1243-1252.
-
(1998)
Curr Biol
, vol.8
, pp. 1243-1252
-
-
Oft, M.1
Heider, K.H.2
Beug, H.3
-
4
-
-
0030056048
-
Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells
-
Wang J, Han W, Zborowska E, Liang J, Wang X, et al. (1996) Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells. J Biol Chem 271: 17366-17371.
-
(1996)
J Biol Chem
, vol.271
, pp. 17366-17371
-
-
Wang, J.1
Han, W.2
Zborowska, E.3
Liang, J.4
Wang, X.5
-
5
-
-
0033568528
-
Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells
-
Ye SC, Foster JM, Li W, Liang J, Zborowska E, et al. (1999) Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Cancer Res 59: 4725-4731.
-
(1999)
Cancer Res
, vol.59
, pp. 4725-4731
-
-
Ye, S.C.1
Foster, J.M.2
Li, W.3
Liang, J.4
Zborowska, E.5
-
6
-
-
0029131403
-
Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells
-
Wang J, Sun L, Myeroff L, Wang X, Gentry LE, et al. (1995) Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270: 22044-22049.
-
(1995)
J Biol Chem
, vol.270
, pp. 22044-22049
-
-
Wang, J.1
Sun, L.2
Myeroff, L.3
Wang, X.4
Gentry, L.E.5
-
7
-
-
0029066689
-
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability
-
Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, et al. (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338.
-
(1995)
Science
, vol.268
, pp. 1336-1338
-
-
Markowitz, S.1
Wang, J.2
Myeroff, L.3
Parsons, R.4
Sun, L.5
-
8
-
-
0028075837
-
Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells
-
Sun L, Wu G, Willson JK, Zborowska E, Yang J, et al. (1994) Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269: 26449-26455.
-
(1994)
J Biol Chem
, vol.269
, pp. 26449-26455
-
-
Sun, L.1
Wu, G.2
Willson, J.K.3
Zborowska, E.4
Yang, J.5
-
9
-
-
4544359282
-
Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity
-
Wang J, Sergina N, Ko TC, Gong J, Brattain MG, (2004) Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity. J Biol Chem 279: 40237-40244.
-
(2004)
J Biol Chem
, vol.279
, pp. 40237-40244
-
-
Wang, J.1
Sergina, N.2
Ko, T.C.3
Gong, J.4
Brattain, M.G.5
-
10
-
-
0026513154
-
TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector
-
Wu SP, Theodorescu D, Kerbel RS, Willson JK, Mulder KM, et al. (1992) TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J Cell Biol 116: 187-196.
-
(1992)
J Cell Biol
, vol.116
, pp. 187-196
-
-
Wu, S.P.1
Theodorescu, D.2
Kerbel, R.S.3
Willson, J.K.4
Mulder, K.M.5
-
11
-
-
0027548803
-
Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties
-
Wu SP, Sun LZ, Willson JK, Humphrey L, Kerbel R, et al. (1993) Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Cell Growth Differ 4: 115-123.
-
(1993)
Cell Growth Differ
, vol.4
, pp. 115-123
-
-
Wu, S.P.1
Sun, L.Z.2
Willson, J.K.3
Humphrey, L.4
Kerbel, R.5
-
12
-
-
84861815484
-
Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells
-
Simms N, Rajput A, Sharratt EA, Ongchin M, Teggart CA, et al. (2012) Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells. BMC Cancer 12: 221.
-
(2012)
BMC Cancer
, vol.12
, pp. 221
-
-
Simms, N.1
Rajput, A.2
Sharratt, E.A.3
Ongchin, M.4
Teggart, C.A.5
-
13
-
-
0031039243
-
The biology of vascular endothelial growth factor
-
Ferrara N, Davis-Smyth T, (1997) The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25.
-
(1997)
Endocr Rev
, vol.18
, pp. 4-25
-
-
Ferrara, N.1
Davis-Smyth, T.2
-
14
-
-
27944473690
-
VEGF as a key mediator of angiogenesis in cancer
-
Carmeliet P, (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69Suppl 3: 4-10.
-
(2005)
Oncology
, vol.69
, pp. 4-10
-
-
Carmeliet, P.1
-
15
-
-
0037967272
-
Tumorigenesis and the angiogenic switch
-
Bergers G, Benjamin LE, (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 401-410
-
-
Bergers, G.1
Benjamin, L.E.2
-
16
-
-
0032537757
-
Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription
-
Akiri G, Nahari D, Finkelstein Y, Le SY, Elroy-Stein O, et al. (1998) Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription. Oncogene 17: 227-236.
-
(1998)
Oncogene
, vol.17
, pp. 227-236
-
-
Akiri, G.1
Nahari, D.2
Finkelstein, Y.3
Le, S.Y.4
Elroy-Stein, O.5
-
17
-
-
33847058369
-
Translational induction of VEGF internal ribosome entry site elements during the early response to ischemic stress
-
Bornes S, Prado-Lourenco L, Bastide A, Zanibellato C, Iacovoni JS, et al. (2007) Translational induction of VEGF internal ribosome entry site elements during the early response to ischemic stress. Circ Res 100: 305-308.
-
(2007)
Circ Res
, vol.100
, pp. 305-308
-
-
Bornes, S.1
Prado-Lourenco, L.2
Bastide, A.3
Zanibellato, C.4
Iacovoni, J.S.5
-
18
-
-
0035958932
-
The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits HIF-1-mediated transcription
-
Fatyol K, Szalay AA, (2001) The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits HIF-1-mediated transcription. J Biol Chem 276: 28421-28429.
-
(2001)
J Biol Chem
, vol.276
, pp. 28421-28429
-
-
Fatyol, K.1
Szalay, A.A.2
-
19
-
-
0029761644
-
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
-
Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613.
-
(1996)
Mol Cell Biol
, vol.16
, pp. 4604-4613
-
-
Forsythe, J.A.1
Jiang, B.H.2
Iyer, N.V.3
Agani, F.4
Leung, S.W.5
-
20
-
-
2342586778
-
Involvement of ERK1/2 pathway in TGF-beta1-induced VEGF secretion in normal human cytotrophoblast cells
-
Qian D, Lin HY, Wang HM, Zhang X, Liu DL, et al. (2004) Involvement of ERK1/2 pathway in TGF-beta1-induced VEGF secretion in normal human cytotrophoblast cells. Mol Reprod Dev 68: 198-204.
-
(2004)
Mol Reprod Dev
, vol.68
, pp. 198-204
-
-
Qian, D.1
Lin, H.Y.2
Wang, H.M.3
Zhang, X.4
Liu, D.L.5
-
21
-
-
33845498127
-
TGF-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro
-
Riedel K, Riedel F, Goessler UR, Germann G, Sauerbier M, (2007) TGF-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro. Arch Med Res 38: 45-51.
-
(2007)
Arch Med Res
, vol.38
, pp. 45-51
-
-
Riedel, K.1
Riedel, F.2
Goessler, U.R.3
Germann, G.4
Sauerbier, M.5
-
22
-
-
33846696437
-
A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo
-
Rajput A, Koterba AP, Kreisberg JI, Foster JM, Willson JK, et al. (2007) A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo. Cancer Res 67: 665-673.
-
(2007)
Cancer Res
, vol.67
, pp. 665-673
-
-
Rajput, A.1
Koterba, A.P.2
Kreisberg, J.I.3
Foster, J.M.4
Willson, J.K.5
-
23
-
-
0037099745
-
TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses
-
Yu L, Hebert MC, Zhang YE, (2002) TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 21: 3749-3759.
-
(2002)
EMBO J
, vol.21
, pp. 3749-3759
-
-
Yu, L.1
Hebert, M.C.2
Zhang, Y.E.3
-
24
-
-
72849141590
-
Prohibitin regulates TGF-beta induced apoptosis as a downstream effector of Smad-dependent and -independent signaling
-
Zhu B, Zhai J, Zhu H, Kyprianou N, (2010) Prohibitin regulates TGF-beta induced apoptosis as a downstream effector of Smad-dependent and-independent signaling. Prostate 70: 17-26.
-
(2010)
Prostate
, vol.70
, pp. 17-26
-
-
Zhu, B.1
Zhai, J.2
Zhu, H.3
Kyprianou, N.4
-
25
-
-
79955783609
-
Identification of a novel TGF-beta/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer
-
Chowdhury S, Howell GM, Rajput A, Teggart CA, Brattain LE, et al. (2011) Identification of a novel TGF-beta/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer. PLoS ONE 6: e19335.
-
(2011)
PLoS ONE
, vol.6
-
-
Chowdhury, S.1
Howell, G.M.2
Rajput, A.3
Teggart, C.A.4
Brattain, L.E.5
-
26
-
-
84872510974
-
SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer
-
Fleming N, Jorissen RN, Mouradov D, Christie M, Sakthianandeswaren A, et al. (2012) SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Cancer Res.
-
(2012)
Cancer Res
-
-
Fleming, N.1
Jorissen, R.N.2
Mouradov, D.3
Christie, M.4
Sakthianandeswaren, A.5
-
27
-
-
44849127680
-
ransforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells
-
Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, et al. (2008) ransforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells. Cancer Res 68: 3152-3160.
-
(2008)
Cancer Res
, vol.68
, pp. 3152-3160
-
-
Wang, J.1
Yang, L.2
Yang, J.3
Kuropatwinski, K.4
Wang, W.5
-
28
-
-
17444383660
-
Apoptosome dysfunction in human cancer
-
Hajra KM, Liu JR, (2004) Apoptosome dysfunction in human cancer. Apoptosis 9: 691-704.
-
(2004)
Apoptosis
, vol.9
, pp. 691-704
-
-
Hajra, K.M.1
Liu, J.R.2
-
29
-
-
34548575184
-
Loss of Smad4 expression predicts liver metastasis in human colorectal cancer
-
Losi L, Bouzourene H, Benhattar J, (2007) Loss of Smad4 expression predicts liver metastasis in human colorectal cancer. Oncol Rep 17: 1095-1099.
-
(2007)
Oncol Rep
, vol.17
, pp. 1095-1099
-
-
Losi, L.1
Bouzourene, H.2
Benhattar, J.3
-
30
-
-
0033587156
-
Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis
-
Miyaki M, Iijima T, Konishi M, Sakai K, Ishii A, et al. (1999) Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18: 3098-3103.
-
(1999)
Oncogene
, vol.18
, pp. 3098-3103
-
-
Miyaki, M.1
Iijima, T.2
Konishi, M.3
Sakai, K.4
Ishii, A.5
-
31
-
-
77249140520
-
Antimetastatic role of Smad4 signaling in colorectal cancer
-
Zhang B, Halder SK, Kashikar ND, Cho YJ, Datta A, et al. (2010) Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology 138: 969-980.
-
(2010)
Gastroenterology
, vol.138
, pp. 969-980
-
-
Zhang, B.1
Halder, S.K.2
Kashikar, N.D.3
Cho, Y.J.4
Datta, A.5
-
32
-
-
79551605347
-
Smad4 inactivation promotes malignancy and drug resistance of colon cancer
-
Papageorgis P, Cheng K, Ozturk S, Gong Y, Lambert AW, et al. (2011) Smad4 inactivation promotes malignancy and drug resistance of colon cancer. Cancer Res 71: 998-1008.
-
(2011)
Cancer Res
, vol.71
, pp. 998-1008
-
-
Papageorgis, P.1
Cheng, K.2
Ozturk, S.3
Gong, Y.4
Lambert, A.W.5
-
33
-
-
58149150071
-
VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival
-
Bendardaf R, Buhmeida A, Hilska M, Laato M, Syrjanen S, et al. (2008) VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival. Anticancer Res 28: 3865-3870.
-
(2008)
Anticancer Res
, vol.28
, pp. 3865-3870
-
-
Bendardaf, R.1
Buhmeida, A.2
Hilska, M.3
Laato, M.4
Syrjanen, S.5
-
34
-
-
79953191763
-
FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer
-
Bertolini F, Malavasi N, Scarabelli L, Fiocchi F, Bagni B, et al. (2011) FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer. Br J Cancer 104: 1079-1084.
-
(2011)
Br J Cancer
, vol.104
, pp. 1079-1084
-
-
Bertolini, F.1
Malavasi, N.2
Scarabelli, L.3
Fiocchi, F.4
Bagni, B.5
-
35
-
-
77954954904
-
Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX
-
Klinger M, Tamandl D, Eipeldauer S, Hacker S, Herberger B, et al. (2010) Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX. Ann Surg Oncol 17: 2059-2065.
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 2059-2065
-
-
Klinger, M.1
Tamandl, D.2
Eipeldauer, S.3
Hacker, S.4
Herberger, B.5
-
36
-
-
84865243485
-
Overcoming Resistance to Antiangiogenic Therapies
-
Tejpar S, Prenen H, Mazzone M, (2012) Overcoming Resistance to Antiangiogenic Therapies. Oncologist 17: 1039-1050.
-
(2012)
Oncologist
, vol.17
, pp. 1039-1050
-
-
Tejpar, S.1
Prenen, H.2
Mazzone, M.3
|